ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS — Department of Health and Human Services SBIR Phase I: The main objective of this contract is to generate VHH antibodies against 10 addiction-rel
ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS — SBIR Phase I award from Department of Health and Human Services.
- Amount
- $200,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase I
- NAICS
- —
- Place of performance
- CA
- Period
- —
Description
The main objective of this contract is to generate VHH antibodies against 10 addiction-relevant proteins. Protocols will be established for efficiently identifying single chain VHH antibodies from llamas. Both synthetic peptides and recombinant proteinswill be used to immunize llamas.